Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > People selling taking profits today that bought in.17 to .22
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(96)
•••
Comment by aYozzzon Aug 23, 2021 2:49pm
122 Views
Post# 33749433

RE:RE:RE:People selling taking profits today that bought in.17 to .22

RE:RE:RE:People selling taking profits today that bought in.17 to .22Go pump syqe a little more. How's their FDA trial going? Have they even started? If you know the cycle why would you hold at 30cents if it's going back to 20? Your soft bashing is hilarious. Clueless basher: "I'm long at 30cents but it's going back to 20" that might be the dumbest thing I read all day.
SamV21 wrote: Perhaps you would like to buy my shares for 1.00 , I have heard they are worth 3 to 5.cut me a cheque for 1,000,000 and I am gone, assume someone that does any DD here must be short any one that works the market knows to sell some off some of  the pile on a gain day when any results are 2 years away, phase 2 is as far as most trials go , go do some FDA  research , once again commenting on the poster trying to defend the fake news and hype.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities